Show simple item record

dc.contributor.authorAkyol, Sumeyya
dc.contributor.authorUgurcu, Veli
dc.contributor.authorAltuntas, Aynur
dc.contributor.authorHasgul, Rukiye
dc.contributor.authorCakmak, Ozlem
dc.contributor.authorAkyol, Omer
dc.date.accessioned2019-12-16T10:29:13Z
dc.date.available2019-12-16T10:29:13Z
dc.date.issued2014
dc.identifier.issn2356-6140
dc.identifier.urihttps://doi.org/10.1155/2014/561971
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065767/
dc.identifier.urihttp://hdl.handle.net/11655/20071
dc.description.abstractCaffeic acid phenethyl ester (CAPE), an active component of propolis, has been attracting the attention of different medical and pharmaceutical disciplines in recent years because of its antioxidant, anti-inflammatory, antiproliferative, cytotoxic, antiviral, antifungal, and antineoplastic properties. One of the most studied organs for the effects of CAPE is the kidney, particularly in the capacity of this ester to decrease the nephrotoxicity induced by several drugs and the oxidative injury after ischemia/reperfusion (I/R). In this review, we summarized and critically evaluated the current knowledge regarding the protective effect of CAPE in nephrotoxicity induced by several special medicines such as cisplatin, doxorubicin, cyclosporine, gentamycin, methotrexate, and other causes leading to oxidative renal injury, namely, I/R models and senility.
dc.relation.isversionof10.1155/2014/561971
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleCaffeic Acid Phenethyl Ester As a Protective Agent Against Nephrotoxicity and/or Oxidative Kidney Damage: A Detailed Systematic Review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalThe Scientific World Journal
dc.contributor.departmentBiyokimya
dc.identifier.volume2014
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record